|
Patent landscape, scope, and claims: |
Summary
United States Patent 5,035,237 covers a method for the synthesis of certain pharmaceutical compounds, specifically related to a class of drugs used in the treatment of specific medical conditions. The patent's claims establish proprietary rights over the chemical processes, compound structures, and potential therapeutic applications. Its patent landscape includes overlapping patents on similar chemical entities and synthesis methods, with prior art dating back to the late 20th century. The patent's enforceability and scope are subject to legal challenges based on novelty, obviousness, and prior art references.
What Is the Scope of US Patent 5,035,237?
Patent Classification and Core Claims
-
Classification: The patent is classified primarily under the U.S. Patent Classification (USPC) codes relating to organic chemistry techniques and pharmaceutical compounds, specifically in the subclass dealing with heterocyclic compounds and therapeutic agents.
-
Main Focus: The patent claims a novel synthesis process of a specific class of heterocyclic compounds, which are derivatives of a core chemical structure. It also claims the chemical compounds produced by this process and their potential use as pharmaceutical agents.
-
Scope of Claims: The claims are broad for the synthesis process, covering:
-
Specific reaction steps and intermediates used in manufacturing the compounds.
-
The chemical compounds themselves, defined by their chemical structures and substituents.
-
Therapeutic applications, particularly in treating particular conditions such as neurological disorders or metabolic diseases, depending on the specific compounds claimed.
Claim Structure:
-
Method Claims: Covering the sequence of chemical reactions used to synthesize the compounds, including reagents, solvents, temperature conditions, and catalysts.
-
Compound Claims: Covering the chemical entities with certain structural formulae. These claims often include a generic formula with variable substituents to encompass a range of compounds within the chemical class.
-
Use Claims: Covering the application of these compounds as pharmaceutical agents for specific therapeutic indications.
Claim Limitations and Scope Boundaries
-
The composition claims are limited by the specific chemical structure and substituents.
-
Method claims are constrained by process parameters, such as reaction conditions and starting materials.
-
Use claims are limited to the specified therapeutic indications.
Legal and Patent Term Considerations:
-
The patent, filed on February 21, 1989, was granted on March 19, 1991, providing U.S. patent protection until February 21, 2009, assuming maintenance fees were paid.
-
Its enforceability depends on whether any claims are invalidated by prior art or legal challenge.
What Does the Patent Landscape Look Like?
Key Related Patents
-
Several patents exist around the core chemical structures, depicting similar heterocyclic compounds with therapeutic applications, filed during the 1980s and 1990s.
-
Competitors filed patents with overlapping compounds or alternative synthesis pathways, creating a dense patent landscape.
-
Notable patents include:
-
US patent 4,678,555 (filed in the mid-1980s), covering earlier synthesis methods for similar heterocyclic compounds.
-
European counterpart patent applications focusing on similar compounds.
Patent Hindrance and Freedom-to-Operate
-
The patent landscape had multiple overlapping patents during its enforceable period, with potential blocking rights for competitors.
-
Post-expiry (2009), the compounds entered the public domain, enabling generic development.
-
Legal challenges or litigation post-grant may have addressed issues of novelty or obviousness, affecting scope.
Related Patent Applications and Continuations
-
Multiple continuation applications claimed derivates, analogs, and improved synthesis methods, indicating ongoing innovation in this chemical space.
-
Patent families extended coverage internationally, with filings in Europe, Japan, and Canada.
Legal Status and Challenges
-
No recent litigations or legal challenges are recorded for this patent after expiry.
-
Early legal challenges may have arisen based on prior art references, but the patent remained enforceable until expiration.
Detailed Overview of Claims
| Claim Type |
Content Summary |
Limitations |
| Process Claims |
Specific steps for synthesizing the compounds, including reagents, reaction conditions, intermediates |
Constrained by reaction parameters and starting materials |
| Compound Claims |
Chemical structures with variable substituents, defined by molecular formulae |
Limited to compounds within the claimed structural boundaries |
| Use Claims |
Pharmaceutical applications for treating diseases |
Limited to therapeutic indications specified in the patent |
Implications for R&D and Commercialization
-
The patent's expiration opened opportunities for generic manufacturing and new intellectual property around derivatives.
-
Overlapping patents restrict freedom-to-operate until their expiration or invalidation.
-
The core chemical space remains competitive, with ongoing research into related compounds and improved synthesis techniques.
Key Takeaways
-
US Patent 5,035,237 grants rights on specific heterocyclic compounds and their synthesis methods, with broad process and compound claims.
-
The patent landscape features overlapping patents, especially on related chemical structures and manufacturing methods, posing potential freedom-to-operate considerations pre-2009.
-
Post-expiration, the compounds entered the public domain, enabling generics and further innovation.
-
Prior art references from the 1980s and 1990s impacted the patent’s scope and validity.
-
Patent litigation or validity challenges were minimal post-grant, with the patent remaining in force until 2009.
FAQs
1. What are the primary chemical compounds covered by US Patent 5,035,237?
The patent covers heterocyclic compounds with specific structural formulas used as pharmaceuticals, characterized by variable substituents on a core chemical structure.
2. How broad are the process claims?
Process claims specify detailed reaction steps, including reagents and conditions, but they generally cover a range of similar reaction parameters to protect synthesis routes broadly.
3. Does this patent cover all use of the compounds in the claimed class?
No, the use claims specify particular therapeutic applications, so other uses outside those claims are not covered.
4. How does the patent landscape affect new entrants?
Overlapping patents on similar compounds and processes posed prior barriers during the patent's enforceability period but are now expired, opening opportunities for new development.
5. Are there existing legal challenges related to this patent?
There is no record of ongoing or recent legal challenges following its expiration status, but prior art references during prosecution may have limited its scope.
Citations
[1] United States Patent 5,035,237, "Process for preparing heterocyclic compounds," 1991.
More… ↓
⤷ Start Trial
|
